Ion Beam Applications SA
After founding IBA in 1986, he served as general manager and co-general manager of the company until March 2000, when he assumed his current role. Prior to founding IBA, Mr. Jongen served for 16 years as manager of the UCL Cyclotron Research Center of the Catholic University of Louvain-la-Neuve (UCL).
This person is not in any offices
Ion Beam Applications SA
3 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.